BM
PDLI

Bill Miller’s PDL BioPharma, Inc. PDLI Stock Holding History

Bill Miller’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-76,400
Closed -$645K – 124
2013
Q4 		$645K Hold
76,400
– – 0.03% 82
2013
Q3 		$609K Hold
76,400
– – 0.04% 75
2013
Q2 		$590K Buy
+76,400
New +$596K 0.04% 75

Other funds holding PDLI

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bill Miller's PDLI Position: Q1 2014 in Review

Bill Miller sold out of PDL BioPharma, Inc. (PDLI) in Q1 2014, closing a stake of 76,400 shares — an estimated $645K sold.

Bill Miller first reported a position in PDLI in Q2 2013 and held it in 3 quarters. The position peaked at $645K in Q4 2013. 233 funds tracked by Wall St. Rank hold PDLI as of Q1 2014.

  • Bill Miller reported no remaining PDL BioPharma, Inc. position as of Q1 2014 after selling out during the quarter.
  • Bill Miller sold 76,400 PDL BioPharma, Inc. shares in Q1 2014, an estimated $645K.
  • Bill Miller first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 3 quarters.
  • Bill Miller's PDL BioPharma, Inc. position peaked at $645K in Q4 2013.
  • 233 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2014.

Based on Miller Value Partners's 13F filing for Q1 2014, filed 15 May 2014.